ArticleScientific reports2025
Nuclear localization and upregulation of BAI1 in alveolar macrophages during LPS-Induced acute lung injury.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Neutrophil-macrophage crosstalk network in acute lung injury: feedback circuits linking cytokine storm and cell death.Frontiers in cellular and infection microbiology · 2026Review
- BAI adhesion-GPCRs perform distinct functions in neural development differentially controlled by RTN4R and C1ql ligands.Nature communications · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Brain-specific angiogenesis inhibitor-1 (BAI1) is an endocytic scavenger receptor that mediates macrophage clearance of apoptotic or phosphatidylserine-expressing cells. Previous studies have shown that BAI1 was localized in the cellular cytoplasm and membrane. However, currently there is no available information regarding the distribution of BAI1 expression in alveolar macrophages (AMs) or its specific role in acute lung injury (ALI). The aim of this study was to preliminarily investigate BAI1 expression in AMs and changes in BAI1 expression levels in an ALI model. A mouse model of ALI was established through intratracheal instillation of a 2 mg/kg LPS. The expression of BAI1 in lung tissues was quantified using immunohistochemistry staining, while the expression of BAI1 in AMs in bronchoalveolar lavage fluid (BALF) was examined through immunofluorescence. Additionally, the MH-S cells were treated with LPS to investigate the distribution and changes in BAI1 expression levels, which were detected using immunofluorescence and Western Blot. Results showed that BAI1 protein was found to be localized in the cellular nuclei in AMs. Moreover, the BAI1 expression level was observed to escalate with the rising concentration of LPS in MH-S cells and in AMs of lungs from ALI mice. Finally, the upregulation of BAI1 expression in MH-S cells induced by LPS was associated with a decrease in the efferocytosis of MH-S cells. The discovery of BAI1 expression in the nuclei of AMs in ALI mice is a novel finding. It is plausible that BAI1 protein may participate in efferocytosis of AMs during ALI through novel signaling pathways.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.